Physician profile
Nilamkumar Patel
NPI 1376664672
$17,264.42
in general payments reported to CMS, 2019-2025
47 companies · $1,435 in 2025
The $1,435 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,155 · 2020: $821 · 2021: $1,980 · 2022: $1,910 · 2023: $1,622 · 2024: $5,342 · 2025: $1,435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,655 · Travel and Lodging: $2,744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,655.37 |
| Travel and Lodging | $2,743.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,001.94 | 2019-2025 | Watchman Flx, Watchman Access System, Emblem Mri S-Icd |
| Abbott Laboratories | $2,787.50 | 2019-2025 | Aveir, Navitor, Amplatzer Amulet |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,461.41 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $1,454.09 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $962.01 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $511.29 | 2019-2023 | Uptravi, Opsumit |
| Janssen Pharmaceuticals, INC | $487.39 | 2019-2024 | Xarelto |
| Pfizer INC. | $407.01 | 2019-2025 | |
| Medtronic, INC. | $400.62 | 2021-2024 | Arctic Front Advance, Pulseselect |
| Biosense Webster, INC. | $378.17 | 2022-2025 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $358.42 | 2019-2025 | Camzyos |
| Amgen INC. | $309.44 | 2019-2023 | Repatha |
| Atricure, INC. | $276.43 | 2024-2025 | Epi-Ease Epicardial Access System, Synergy Ablation System |
| Philips North America LLC | $227.54 | 2022-2025 | (Ck4) Mcot, Ambulatory Monitoring & Diagnostics Undivided |
| Astrazeneca Pharmaceuticals Lp | $221.18 | 2019-2025 | Wainua, Farxiga |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nilamkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.